Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-12-16 Sale |
2020-12-18 4:51 pm |
Arcus Biosciences Inc. | RCUS | Grossman William Chief Medical Officer |
2,117 | $31.35 | $66,368 | 6,727 (Direct) |
View |
2020-09-09 Purchase |
2020-09-09 4:53 pm |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
5,000 | $21.57 | $107,849 | 5,000 (Direct) |
View |
2020-08-07 Purchase |
2020-08-11 5:13 pm |
Arcus Biosciences Inc. | RCUS | ROSEN TERRY J Chief Executive Officer |
43,705 | $22.86 | $999,314 | 4,256,237 (Indirect Direct) |
View |
2020-07-31 Purchase |
2020-08-04 6:13 pm |
Arcus Biosciences Inc. | RCUS | Grossman William Chief Medical Officer |
200 | $19.72 | $3,945 | 600 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-19 Option Award |
2021-01-20 4:10 pm |
N/A 2031-01-18 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
87,500 | $0 | 92,500 (Direct) |
View |
Ownership |
2021-01-06 4:20 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Quigley Michael Director |
0 | $0 | 0 (Direct) |
View |
2020-12-17 Option Award |
2020-12-18 7:58 pm |
N/A 2030-12-16 |
Arcus Biosciences Inc. | RCUS | PERLMAN ANDREW J Director |
25,500 | $0 | 28,025 (Direct) |
View |
Ownership |
2020-12-18 4:21 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Tang Carolyn C. General Counsel |
0 | $0 | 440,348 (Direct) |
View |
Ownership |
2020-12-18 4:17 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | PERLMAN ANDREW J Director |
0 | $0 | 2,525 (Direct) |
View |
2020-10-13 Gift |
2020-10-15 4:46 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Jaen Juan C. President |
1,207,000 | $0 | 1,761,633 (Indirect) |
View |
2020-10-02 Option Award |
2020-10-05 5:02 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Grossman William Chief Medical Officer |
100,000 | $0 | 200,600 (Direct) |
View |
2020-10-02 Option Award |
2020-10-05 5:02 pm |
N/A 2030-10-01 |
Arcus Biosciences Inc. | RCUS | Grossman William Chief Medical Officer |
100,000 | $17 | 200,600 (Direct) |
View |
2020-10-01 Option Award |
2020-10-05 5:01 pm |
N/A 2030-09-30 |
Arcus Biosciences Inc. | RCUS | Jarrett Jennifer Chief Operating Officer |
900,000 | $0 | 1,000,634 (Direct) |
View |
2020-08-03 Option Award |
2020-08-04 6:53 pm |
N/A 2030-07-31 |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
250,000 | $0 | 250,000 (Direct) |
View |
Ownership |
2020-08-04 6:15 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Goeltz II Robert C. Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
Ownership |
2020-07-17 2:00 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC 10% Owner |
0 | $0 | 8,163,029 (Direct) |
View |
Ownership |
2020-07-13 5:59 pm |
N/A N/A |
Arcus Biosciences Inc. | RCUS | Parsey Merdad Director |
0 | $0 | 0 (Direct) |
View |